Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Heindel

Showing results (111-120 of 132) with videos related to

Pageof 14
Sort By:
Reproductive Toxicology (Elmsford, N.Y.)|July 20, 2020
Data integration, analysis, and interpretation of eight academic CLARITY-BPA studiesJerrold J Heindel, Scott Belcher, Jodi A Flaws, et al.
Molecular Endocrinology (Baltimore, Md.)|August 2, 2016
Minireview: Endocrine Disruptors: Past Lessons and Future DirectionsThaddeus T Schug, Anne F Johnson, Linda S Birnbaum, et al.
Andrology|March 23, 2016
Burden of disease and costs of exposure to endocrine disrupting chemicals in the European Union: an updated analysisL Trasande, R T Zoeller, U Hass, et al.
Endocrine Reviews|March 16, 2012
Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responsesLaura N Vandenberg, Theo Colborn, Tyrone B Hayes, et al.
Reproductive Toxicology (Elmsford, N.Y.)|February 16, 2013
Regulatory decisions on endocrine disrupting chemicals should be based on the principles of endocrinologyLaura N Vandenberg, Theo Colborn, Tyrone B Hayes, et al.
Basic & Clinical Pharmacology & Toxicology|November 3, 2018
Timescales of developmental toxicity impacting on research and needs for interventionPhilippe Grandjean, Latifa Abdennebi-Najar, Robert Barouki, et al.
Nature Reviews. Endocrinology|November 29, 2024
Consensus on the key characteristics of metabolism disruptorsMichele A La Merrill, Martyn T Smith, Cliona M McHale, et al.
Environmental Health Perspectives|September 23, 2017
Endocrine Disruptors and Health Effects in Africa: A Call for ActionMaria S Bornman, Natalie H Aneck-Hahn, Christiaan de Jager, et al.
Biochemical Pharmacology|April 8, 2022
Obesity I: Overview and molecular and biochemical mechanismsRobert H Lustig, David Collier, Christopher Kassotis, et al.
Biochemical Pharmacology|April 8, 2022
Obesity III: Obesogen assays: Limitations, strengths, and new directionsChristopher D Kassotis, Frederick S Vom Saal, Patrick J Babin, et al.
Pageof 14

Showing results (111-120 of 132) with videos related to

Sort By:
Pageof 14
Reproductive Toxicology (Elmsford, N.Y.)|July 20, 2020
Data integration, analysis, and interpretation of eight academic CLARITY-BPA studiesJerrold J Heindel, Scott Belcher, Jodi A Flaws, et al.
Molecular Endocrinology (Baltimore, Md.)|August 2, 2016
Minireview: Endocrine Disruptors: Past Lessons and Future DirectionsThaddeus T Schug, Anne F Johnson, Linda S Birnbaum, et al.
Andrology|March 23, 2016
Burden of disease and costs of exposure to endocrine disrupting chemicals in the European Union: an updated analysisL Trasande, R T Zoeller, U Hass, et al.
Endocrine Reviews|March 16, 2012
Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responsesLaura N Vandenberg, Theo Colborn, Tyrone B Hayes, et al.
Reproductive Toxicology (Elmsford, N.Y.)|February 16, 2013
Regulatory decisions on endocrine disrupting chemicals should be based on the principles of endocrinologyLaura N Vandenberg, Theo Colborn, Tyrone B Hayes, et al.
Basic & Clinical Pharmacology & Toxicology|November 3, 2018
Timescales of developmental toxicity impacting on research and needs for interventionPhilippe Grandjean, Latifa Abdennebi-Najar, Robert Barouki, et al.
Nature Reviews. Endocrinology|November 29, 2024
Consensus on the key characteristics of metabolism disruptorsMichele A La Merrill, Martyn T Smith, Cliona M McHale, et al.
Environmental Health Perspectives|September 23, 2017
Endocrine Disruptors and Health Effects in Africa: A Call for ActionMaria S Bornman, Natalie H Aneck-Hahn, Christiaan de Jager, et al.
Biochemical Pharmacology|April 8, 2022
Obesity I: Overview and molecular and biochemical mechanismsRobert H Lustig, David Collier, Christopher Kassotis, et al.
Biochemical Pharmacology|April 8, 2022
Obesity III: Obesogen assays: Limitations, strengths, and new directionsChristopher D Kassotis, Frederick S Vom Saal, Patrick J Babin, et al.
Pageof 14